← Leaderboards
Alison Morris
University Of Pittsburgh At Pittsburgh
$31,399,077
Attributed
$46,901,723
Total exposure
29
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$46,705,581 · 29
AHRQ$2,909,478 · 1
By mechanism
R01$24,927,577 · 8
P01$7,295,552 · 3
T32$3,899,048 · 1
U01$3,843,855 · 1
U18$2,909,478 · 1
K12$1,729,859 · 1
Top collaborators
- Barbara Methe13 shared
- John W Mellors12 shared
- Jessica Bon6 shared
- Panagiotis V Benos5 shared
- Stephen Y Chan5 shared
- Elodie Ghedin5 shared
- Solomon Fiifi Ofori-Acquah5 shared
- Howard B Degenholtz3 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Matthew S Freiberg$20,071,860
- Jessica Bon$4,678,630
- Stephen B. Thomas$4,069,041
- Sandra Crouse Quinn$5,917,072
- Yuanpu Peter Di$9,824,961
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungPathogenesisLung DiseasesCohortInflammationChronic Obstructive Airway DiseasePlayFutureRespiratory PhysiologyPreventChronicResourcesRisk FactorsPersonsSmokerAirway ObstructionInfectionHiv InfectionsCellsProgramsPhenotypeMorbidity - Disease RatePathway InteractionsSmoking
Grant awards (102)
The Pitt IMProving Access to Culturally relevant long COVID care and Treatment (IMPACCT) Program$965,315
U18 · FY2025 · HS · contact PI
Relationship of fungal translocation, inflammation, and pulmonary function in HIV$785,014
R01 · FY2025 · HL
Fungal Translocation in Chronic Obstructive Pulmonary Disease$616,495
R01 · FY2025 · HL
Pittsburgh Innovation in Collaborative Training of Residents Alliance$289,329
R38 · FY2025 · HL
2025 Pittsburgh Lung Conference: The Science of Medicine: Developing the Next Generation of Physician Scientists$35,000
R13 · FY2025 · HL
The Pitt IMProving Access to Culturally relevant long COVID care and Treatment (IMPACCT) Program$964,230
U18 · FY2024 · HS · contact PI
Relationship of fungal translocation, inflammation, and pulmonary function in HIV$785,014
R01 · FY2024 · HL · contact PI
Fungal Translocation in Chronic Obstructive Pulmonary Disease$770,002
R01 · FY2024 · HL
Translational Training Program in Pulmonary Biology and Medicine$507,049
T32 · FY2024 · HL · contact PI
Pittsburgh Innovation in Collaborative Training of Residents Alliance$289,329
R38 · FY2024 · HL
The Third Pittsburgh Rust Belt Microbiome Conference$5,000
R13 · FY2024 · AI
The Pitt IMProving Access to Culturally relevant long COVID care and Treatment (IMPACCT) Program$979,933
U18 · FY2023 · HS · contact PI
Relationship of fungal translocation, inflammation, and pulmonary function in HIV$786,162
R01 · FY2023 · HL · contact PI
Fungal Translocation in Chronic Obstructive Pulmonary Disease$785,641
R01 · FY2023 · HL
Translational Training Program in Pulmonary Biology and Medicine$746,336
T32 · FY2023 · HL · contact PI
Pittsburgh Innovation in Collaborative Training of Residents Alliance$309,456
R38 · FY2023 · HL
Relationship of fungal translocation, inflammation, and pulmonary function in HIV$786,162
R01 · FY2022 · HL · contact PI
Fungal Translocation in Chronic Obstructive Pulmonary Disease$775,691
R01 · FY2022 · HL
Translational Training Program in Pulmonary Biology and Medicine$394,762
T32 · FY2022 · HL · contact PI
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$391,026
K12 · FY2022 · HL · contact PI
Pittsburgh Innovation in Collaborative Training of Residents Alliance$308,611
R38 · FY2022 · HL
The Second Rust Belt Microbiome Conference$7,000
R13 · FY2022 · AI
Systems Biology of Diffusion Impairment in HIV$773,874
R01 · FY2021 · HL · contact PI
Translational Training Program in Pulmonary Biology and Medicine$454,253
T32 · FY2021 · HL · contact PI
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$415,675
K12 · FY2021 · HL · contact PI
2020 Pittsburgh International Lung Conference: Metabolism and the Lung: Homeostasis, Immunity, and Disease$30,000
R13 · FY2021 · HL
Therapeutic Targeting of Vascular Subphenotypes of Lung Disease$2,713,336
P01 · FY2020 · HL · contact PI
Systems Biology of Diffusion Impairment in HIV$774,369
R01 · FY2020 · HL · contact PI
Translational Training Program in Pulmonary Biology and Medicine$584,044
T32 · FY2020 · HL · contact PI
Systems Biology in Vaping Product Exposure$572,242
R01 · FY2020 · HL · contact PI
Dysbiosis Impact on Lung Disease in HIV (DImpL) Study$462,630
R01 · FY2020 · HL · contact PI
Pulmonary hypertension: Genetic, Microbiome and Environmental Determinants$444,087
P01 · FY2020 · HL · contact PI
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$411,577
K12 · FY2020 · HL · contact PI
Systems Biology of Diffusion Impairment in HIV$774,849
R01 · FY2019 · HL · contact PI
Translational Training Program in Pulmonary Biology and Medicine$522,388
T32 · FY2019 · HL · contact PI
Dysbiosis Impact on Lung Disease in HIV (DImpL) Study$464,950
R01 · FY2019 · HL · contact PI
Pulmonary hypertension: Genetic, Microbiome and Environmental Determinants$443,765
P01 · FY2019 · HL · contact PI
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$412,499
K12 · FY2019 · HL · contact PI
Determination of immunogenic microbiota in the lung: leveraging the Lung HIV Microbiome Project$117,375
R21 · FY2019 · HL
2019 Pittsburgh Rust Belt Microbiome Conference$10,000
R13 · FY2019 · GM
Systems Biology of Diffusion Impairment in HIV$775,316
R01 · FY2018 · HL · contact PI
Translational Training Program in Pulmonary Biology and Medicine$690,216
T32 · FY2018 · HL · contact PI
Dysbiosis Impact on Lung Disease in HIV (DImpL) Study$470,004
R01 · FY2018 · HL · contact PI
Pulmonary hypertension: Genetic, Microbiome and Environmental Determinants$445,136
P01 · FY2018 · HL · contact PI
Determination of immunogenic microbiota in the lung: leveraging the Lung HIV Microbiome Project$117,375
R21 · FY2018 · HL
Mentoring and Patient-Oriented Research in HIV Obstructive Lung Disease$114,212
K24 · FY2018 · HL · contact PI
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$99,082
K12 · FY2018 · HL · contact PI
Longitudinal evaluation of HIV-associated lung disease phenotypes$724,214
R01 · FY2017 · HL · contact PI
Translational evaluation of aging, inflammation, and HIV in lung dysfunction$662,017
R01 · FY2017 · HL · contact PI
Dysbiosis Impact on Lung Disease in HIV (DImpL) Study$499,382
R01 · FY2017 · HL · contact PI
Pulmonary hypertension: Genetic, Microbiome and Environmental Determinants$444,437
P01 · FY2017 · HL · contact PI
Dysbiosis Impact on Lung Disease in HIV (DImpL) Study$394,506
R01 · FY2017 · HL · contact PI
Longitudinal evaluation of HIV-associated lung disease phenotypes$190,626
R01 · FY2017 · HL · contact PI
Mentoring and Patient-Oriented Research in HIV Obstructive Lung Disease$114,212
K24 · FY2017 · HL · contact PI
Longitudinal evaluation of HIV-associated lung disease phenotypes$727,308
R01 · FY2016 · HL · contact PI
Translational evaluation of aging, inflammation, and HIV in lung dysfunction$676,488
R01 · FY2016 · HL · contact PI
Pulmonary hypertension: Genetic, Microbiome and Environmental Determinants$469,565
P01 · FY2016 · HL · contact PI
Mentoring and Patient-Oriented Research in HIV Obstructive Lung Disease$114,212
K24 · FY2016 · HL · contact PI
Longitudinal evaluation of HIV-associated lung disease phenotypes$64,994
R01 · FY2016 · HL · contact PI
Longitudinal evaluation of HIV-associated lung disease phenotypes$727,478
R01 · FY2015 · HL · contact PI
Translational evaluation of aging, inflammation, and HIV in lung dysfunction$678,491
R01 · FY2015 · HL · contact PI
Adiposity and airway inflammation in HIV-associated airway disease$653,002
R56 · FY2015 · HL · contact PI
Translational vascular phenomics, genomics, and epidemology$465,356
P01 · FY2015 · HL · contact PI
Mentoring and Patient-Oriented Research in HIV Obstructive Lung Disease$114,212
K24 · FY2015 · HL · contact PI
Longitudinal evaluation of HIV-associated lung disease phenotypes$63,280
R01 · FY2015 · HL · contact PI
Longitudinal evaluation of HIV-associated lung disease phenotypes$770,898
R01 · FY2014 · HL · contact PI
Translational evaluation of aging, inflammation, and HIV in lung dysfunction$681,884
R01 · FY2014 · HL · contact PI
Translational vascular phenomics, genomics, and epidemology$464,059
P01 · FY2014 · HL · contact PI
Mentoring and Patient-Oriented Research in HIV Obstructive Lung Disease$114,212
K24 · FY2014 · HL · contact PI
Aging and Lung Disease: Clinical Impact and Cellular and Molecular Pathways$25,686
R13 · FY2014 · HL
Translational evaluation of aging, inflammation, and HIV in lung dysfunction$686,609
R01 · FY2013 · HL · contact PI
Pathogenesis of Obstruction/Emphysema and the Microbiome (POEM) in HIV$680,171
U01 · FY2013 · HL · contact PI
Statins for Pulmonary and Cardiac Complications of Chronic HIV (The SPARC Trial)$563,422
R34 · FY2013 · HL · contact PI
Translational vascular phenomics, genomics, and epidemology$449,842
P01 · FY2013 · HL · contact PI
Role of Microbial Translocation in Cardiopulmonary Disease in Children with HIV$108,171
R21 · FY2013 · HL · contact PI
Pittsburgh Lung Conference 2013: Acute and chronic lung infections: Novel patho$20,000
R13 · FY2013 · HL · contact PI
Pathogenesis of Obstruction/Emphysema and the Microbiome (POEM) in HIV$786,567
U01 · FY2012 · HL · contact PI
Statins for Pulmonary and Cardiac Complications of Chronic HIV (The SPARC Trial)$623,249
R34 · FY2012 · HL · contact PI
Translational vascular phenomics, genomics, and epidemology$472,565
P01 · FY2012 · HL · contact PI
Role of Microbial Translocation in Cardiopulmonary Disease in Children with HIV$113,625
R21 · FY2012 · HL · contact PI
Pathogenesis of Obstruction/Emphysema and the Microbiome (POEM) in HIV$786,528
U01 · FY2011 · HL · contact PI
Prevalence & Pathogenesis of Pulmonary Disease in a Large Multicenter HIV Cohort$774,906
R01 · FY2011 · HL · contact PI
Translational vascular phenomics, genomics, and epidemology$483,404
P01 · FY2011 · HL · contact PI
Prevalence & Pathogenesis of Pulmonary Disease in a Large Multicenter HIV Cohort$792,629
R01 · FY2010 · HL · contact PI
Pathogenesis of Obstruction/Emphysema and the Microbiome (POEM) in HIV$789,423
U01 · FY2010 · HL · contact PI
Prevalence & Pathogenesis of Pulmonary Disease in a Large Multicenter HIV Cohort$801,522
R01 · FY2009 · HL · contact PI
Pathogenesis of Obstruction/Emphysema and the Microbiome (POEM) in HIV$801,166
U01 · FY2009 · HL · contact PI
Pneumocystis in Pathogenesis of HIV-associated Emphysema$386,925
R01 · FY2009 · HL · contact PI
Pneumocystis in Pathogenesis of HIV-associated Emphysema$261,772
R01 · FY2009 · HL · contact PI
Defining the Role of Pneumocystis in COPD Pathogenesis$75,750
R03 · FY2009 · HL · contact PI
Prevalence & Pathogenesis of Pulmonary Disease in a Large Multicenter HIV Cohort$829,058
R01 · FY2008 · HL · contact PI
Pneumocystis in Pathogenesis of HIV-associated Emphysema$385,257
R01 · FY2008 · HL · contact PI
Defining the Role of Pneumocystis in COPD Pathogenesis$75,750
R03 · FY2008 · HL · contact PI
Prevalence & Pathogenesis of Pulmonary Disease in a Large Multicenter HIV Cohort$821,613
R01 · FY2007 · HL · contact PI
Pneumocystis in Pathogenesis of HIV-associated Emphysema$350,889
R01 · FY2007 · HL · contact PI
Epidemiology and Significance of P carinii Colonization$132,300
K23 · FY2007 · HL · contact PI
Pneumocystis in Pathogenesis of HIV-associated Emphysema$361,843
R01 · FY2006 · HL · contact PI
Epidemiology and Significance of P carinii Colonization$132,300
K23 · FY2006 · HL · contact PI
Pneumocystis in Pathogenesis of HIV-associated Emphysema$454,573
R01 · FY2005 · HL
Epidemiology and Significance of P carinii Colonization$132,300
K23 · FY2005 · HL
Epidemiology and Significance of P carinii Colonization$132,300
K23 · FY2004 · HL
Epidemiology and Significance of P carinii Colonization$132,300
K23 · FY2003 · HL